Owner
Trademark Portfolio
2 results
(current & previous marks)
Refine by Mark/Description🔽
Filed
Registered
Last Activity
Filters
Ownership
0
2
Status
0
0
2
0
0
Mark Type
2
0
0
0
0
2
1
2
1

Owner:
Serial:75407884
Filed:Dec 18, 1997
Classes:1, 3, 5, +1
Registration:2403115
Registered:Nov 14, 2000
Goods & Services
[ pharmaceutical preparations for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; veterinary preparations for the treatment of rabies, obesity, auto-immune diseases, namely, feline immunodeficiency virus and simian immunodeficiency virus, in livestock, domestic pets and wild animals, namely, foxes and rodents; acaricides, algaccides, biopesticides, herbicides, insecticides, miticides, pesticides and weed killers for agricultural, domestic or commercial use; pharmaceutical preparations produced from plants or containing proteins produced from plants, for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; therapeutic proteins, hormones, peptides and their complexes, derivatives and cofactors, namely, human serum albumin, lactoferrin, hemoglobin, collagen and procollagen for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; vaccines including antibodies or glycoproteins, namely, glycoprotein G, lipases, namely, gastric lipase, pancreatic lipase; and medicines and pharmaceutical preparations obtained from genetically modified plants or containing the extracts of genetically modified plants for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies ]; [ Proteins for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, collagen, serum albumin, RNA, DNA and their extracts, amino acids, ribosomes, ceramides, immunostimulating or immunoregulatory hormones, all obtained from plants; and enzymes for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, proteases, hydrolases, lipases, deshydroxylases and cellulases, all obtained from plants ]; [ Chemicals for use in the manufacture of photographic materials, namely, dyes, wetting agents, fixing agents, developing agents, and stabilizers; chemicals for use in the manufacture of paints, dyes, cosmetics, glues and surfactants; chemicals for use in the manufacture of horticultural materials, namely, soil conditioners, fertilizers; chemicals for use in the manufacture of hormones, peptides, enzymes, and proteins, namely, plant and animal and microbial growth hormones, growth regulators and inhibitors, diagnostic reagents, cell growth media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, genetic expression amplifiers ]; Scientific and industrial research, namely biotechnological research on chemical products intended for industry, science, photography, agriculture, horticulture and forestry, on proteins for pharmaceutical use or for cosmetic use, these proteins being produced from plants, on pharmaceutical and veterinary products and hygiene products coming under the pharmaceutical monopoly, on biotechnological products produced from plants; biological and biotechnological laboratory services; research and development work in plant-based biotechnology

Goods & Services
pharmaceutical preparations for the treatment of diseases linked to genetic dysfunction, protein deficiency; veterinary preparations for the treatment of feline immunodeficiency virus, rabies, lipid update insufficiency, obesity, in pets and wild animals; sanitary preparations for domestic and hospital use, namely, bactericides, anti-bacterial hand washes, antiseptics, germicides, and sanitizers; all-purpose disinfectants for medical instruments, premises and patients; dietetic substances for medical use, namely, food for medically restricted diets, diabetics, intravenous nutrition, babies; chemicals for use in the manufacture of diagnostic reagents, biomaterials for use in the biotechnological industry, for scientific use, for use in photography, and for agricultural use, namely, hormones, peptides, enzymes, proteins, growth hormones, growth regulators and inhibitors, cell growth media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, genetic expression amplifiers; biomaterials for use in the manufacture of genetically modified organisms; and chemicals extracted or expressed by genetically modified organisms for use in the manufacture of therapeutics and cosmetics; "MOLECULAR"